These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 38757347)
21. Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives. Zhang M; Serna-Salas S; Damba T; Borghesan M; Demaria M; Moshage H Mech Ageing Dev; 2021 Oct; 199():111572. PubMed ID: 34536446 [TBL] [Abstract][Full Text] [Related]
22. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics? Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049 [TBL] [Abstract][Full Text] [Related]
24. Strategies for late phase preclinical and early clinical trials of senolytics. Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859 [TBL] [Abstract][Full Text] [Related]
25. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
26. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs. Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842 [TBL] [Abstract][Full Text] [Related]
27. Current senolytics: Mode of action, efficacy and limitations, and their future. Rad AN; Grillari J Mech Ageing Dev; 2024 Feb; 217():111888. PubMed ID: 38040344 [TBL] [Abstract][Full Text] [Related]
28. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies. Toutfaire M; Bauwens E; Debacq-Chainiaux F Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343 [TBL] [Abstract][Full Text] [Related]
30. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Pi M; Kuang H; Yue C; Yang Q; Wu A; Li Y; Assaraf YG; Yang DH; Wu S Drug Resist Updat; 2022 Mar; 61():100822. PubMed ID: 35257981 [TBL] [Abstract][Full Text] [Related]
32. A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials. Gonzales MM; Krishnamurthy S; Garbarino V; Daeihagh AS; Gillispie GJ; Deep G; Craft S; Orr ME Mech Ageing Dev; 2021 Dec; 200():111589. PubMed ID: 34687726 [TBL] [Abstract][Full Text] [Related]
33. Chemical Strategies for the Detection and Elimination of Senescent Cells. García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701 [TBL] [Abstract][Full Text] [Related]
34. The costs and benefits of senotherapeutics for human health. Raffaele M; Vinciguerra M Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323 [TBL] [Abstract][Full Text] [Related]
35. Senescent cells and their secretory phenotype as targets for cancer therapy. Velarde MC; Demaria M; Campisi J Interdiscip Top Gerontol; 2013; 38():17-27. PubMed ID: 23503512 [TBL] [Abstract][Full Text] [Related]
36. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Lagoumtzi SM; Chondrogianni N Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756 [TBL] [Abstract][Full Text] [Related]
37. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice. Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S Elife; 2022 May; 11():. PubMed ID: 35507395 [TBL] [Abstract][Full Text] [Related]
38. New Horizons in cellular senescence for clinicians. Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640 [TBL] [Abstract][Full Text] [Related]
40. Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics. Lorenzo EC; Torrance BL; Keilich SR; Al-Naggar I; Harrison A; Xu M; Bartley JM; Haynes L Aging Cell; 2022 Jan; 21(1):e13525. PubMed ID: 34962049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]